Towards Healthcare
Gene Prediction Tools Market Booms at 18.72% CAGR by 2034

Gene Prediction Tools Market Segment Analysis and Strategic Insights

Projections indicate that, the global gene prediction tools market will increase from USD 200 million in 2024 to USD 1113.98 million by 2034, experiencing a CAGR of 18.72% over the next 10 years. Currently, the respective market is driven by the accelerating demand for personalized treatments in different conditions and the reduction in expenditure on sequencing technologies. Furthermore, North America dominated the market due to the presence of a robust research infrastructure, funding facilities, which allow the development of personalized medicine in the growing chronic disease cases.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The market was valued at USD 200 million in 2024, is estimated at USD 237.44 million in 2025, and is projected to reach USD 1113.98 million by 2034, growing at a CAGR of 18.72%.

While North America dominates (42% share in 2024) due to strong R&D ecosystems and chronic disease prevalenc.

AI and ML significantly enhance gene prediction accuracy, reduce analysis time, and support handling of complex genomic datasets.

Key players include Thermo Fisher Scientific, Illumina, Qiagen, Softberry, DNASTAR, Genscript, BGI Genomics, and MedGenome.

High computational and cloud infrastructure costs, data complexity, and ethical issues surrounding genetic data privacy and manipulation are critical restraints.

Increasing regulatory scrutiny around data privacy especially for genetic data, impacts how gene prediction tools are developed and deployed
Any Questions